{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:42:51Z","timestamp":1792226571156,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.suc.2024.04.003","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T23:35:23Z","timestamp":1715297723000},"page":"1281-1293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cholangiocarcinoma"],"prefix":"10.1016","volume":"104","author":[{"given":"Jon M.","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan C.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.suc.2024.04.003_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hpb.12441","article-title":"Intrahepatic cholangiocarcinoma: expert consensus statement","volume":"17","author":"Weber","year":"2015","journal-title":"HPB"},{"issue":"2","key":"10.1016\/j.suc.2024.04.003_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3322\/caac.21759","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.suc.2024.04.003_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","article-title":"Liver resection and transplantation for intrahepatic cholangiocarcinoma","volume":"72","author":"Mazzaferro","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.suc.2024.04.003_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejso.2013.03.010","article-title":"Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma \u2013 A single-center experience","volume":"39","author":"Scheuermann","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.suc.2024.04.003_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.4254\/wjh.v13.i9.1003","article-title":"Advances in the management of cholangiocarcinoma","volume":"13","author":"Zori","year":"2021","journal-title":"World J Hepatol"},{"issue":"9","key":"10.1016\/j.suc.2024.04.003_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.suc.2024.04.003_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1365-182X(17)30670-6","article-title":"Terminology of hepatic anatomy and resections","volume":"1","author":"Strasberg","year":"1999","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.suc.2024.04.003_bib8","first-page":"104","article-title":"Surgical treatment of intrahepatic cholangiocarcinoma: current and emerging principles","volume":"10","author":"Beal","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.suc.2024.04.003_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.sla.0000150166.94732.88","article-title":"Actual long-term outcome of extrahepatic bile duct cancer after surgical resection","volume":"241","author":"Jang","year":"2005","journal-title":"Ann Surg"},{"issue":"22","key":"10.1016\/j.suc.2024.04.003_bib10","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.4254\/wjh.v7.i22.2396","article-title":"Liver transplantation for cholangiocarcinoma: current status and new insights","volume":"7","author":"Sapisoch\u00edn","year":"2015","journal-title":"World J Hepatol"},{"issue":"5","key":"10.1016\/j.suc.2024.04.003_bib11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/SLA.0000000000005641","article-title":"Liver transplantation as a new standard of care in patients with perihilar cholangiocarcinoma? results from an international benchmark study","volume":"276","author":"Breuer","year":"2022","journal-title":"Ann Surg"},{"issue":"S1","key":"10.1016\/j.suc.2024.04.003_bib12","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/lt.24219","article-title":"Liver transplantation for cholangiocarcinoma","volume":"21","author":"Gores","year":"2015","journal-title":"Liver Transplant"},{"issue":"1","key":"10.1016\/j.suc.2024.04.003_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4240\/wjgs.v14.i1.1","article-title":"Current status of liver transplantation for cholangiocarcinoma","volume":"14","author":"Twohig","year":"2022","journal-title":"World J Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.suc.2024.04.003_bib14","first-page":"817","article-title":"Intrahepatic cholangiocarcinoma","volume":"90","author":"Poultsides","year":"2010","journal-title":"Surg Clin"},{"issue":"12","key":"10.1016\/j.suc.2024.04.003_bib15","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1007\/s00464-020-08161-8","article-title":"Minimally invasive surgery for hilar cholangiocarcinoma: a multicenter retrospective analysis of 158 patients","volume":"35","author":"Jingdong","year":"2021","journal-title":"Surg Endosc"},{"issue":"10","key":"10.1016\/j.suc.2024.04.003_bib16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamasurg.2020.2623","article-title":"Changes in performance of more than 1000\u00a0minimally invasive liver resections","volume":"155","author":"Swaid","year":"2020","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.suc.2024.04.003_bib17","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3390\/cancers14041046","article-title":"Robotic surgery for biliary tract cancer","volume":"14","author":"Kone","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.suc.2024.04.003_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","article-title":"Systemic therapies for intrahepatic cholangiocarcinoma","volume":"72","author":"Kelley","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.suc.2024.04.003_bib19","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jvir.2013.03.019","article-title":"Metaanalysis of survival, complications, and imaging response following chemotherapy-based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinoma","volume":"24","author":"Ray","year":"2013","journal-title":"J\u00a0Vasc Intervent Radiol"},{"issue":"2","key":"10.1016\/j.suc.2024.04.003_bib20","doi-asserted-by":"crossref","first-page":"W205","DOI":"10.2214\/AJR.10.4937","article-title":"Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma","volume":"196","author":"Kim","year":"2011","journal-title":"Am J Roentgenol"},{"issue":"02","key":"10.1016\/j.suc.2024.04.003_bib21","doi-asserted-by":"crossref","first-page":"092","DOI":"10.1055\/s-0037-1602591","article-title":"Decision making: intra-arterial therapies for cholangiocarcinoma\u2014TACE and TARE","volume":"34","author":"Currie","year":"2017","journal-title":"Semin Intervent Radiol"},{"issue":"7","key":"10.1016\/j.suc.2024.04.003_bib22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/jamasurg.2022.1298","article-title":"Comparison of hepatic arterial infusion pump chemotherapy vs resection for patients with multifocal intrahepatic cholangiocarcinoma","volume":"157","author":"Franssen","year":"2022","journal-title":"JAMA Surg"},{"issue":"9","key":"10.1016\/j.suc.2024.04.003_bib23","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.32740","article-title":"Germline alterations in patients with biliary tract cancers: a spectrum of significant and previously underappreciated findings","volume":"126","author":"Maynard","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.suc.2024.04.003_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1245\/ASO.2003.03.091","article-title":"The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases","volume":"10","author":"D?Angelica","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2024.04.003_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2007.07.002","article-title":"18F-fluorodeoxyglucose Positron Emission Tomography Influences Management Decisions in Patients with Biliary Cancer","volume":"206","author":"Corvera","year":"2008","journal-title":"J\u00a0Am Coll Surg"},{"issue":"5","key":"10.1016\/j.suc.2024.04.003_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00464-005-0583-x","article-title":"Utility of staging laparoscopy in subsets of biliary cancers","volume":"20","author":"Goere","year":"2006","journal-title":"Surg Endosc"},{"issue":"11","key":"10.1016\/j.suc.2024.04.003_bib27","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00259-003-1297-8","article-title":"Usefulness of 18 F-FDG PET in intrahepatic cholangiocarcinoma","volume":"30","author":"Kim","year":"2003","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"6","key":"10.1016\/j.suc.2024.04.003_bib28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.suc.2024.04.003_bib29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2206834","article-title":"Futibatinib for FGFR2 -rearranged intrahepatic cholangiocarcinoma","volume":"388","author":"Goyal","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.suc.2024.04.003_bib30","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evidence"},{"issue":"3","key":"10.1016\/j.suc.2024.04.003_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1148\/rg.293085729","article-title":"Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation","volume":"29","author":"Chung","year":"2009","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.suc.2024.04.003_bib32","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2214\/ajr.176.6.1761499","article-title":"MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation","volume":"176","author":"Maetani","year":"2001","journal-title":"Am J Roentgenol"},{"issue":"9","key":"10.1016\/j.suc.2024.04.003_bib33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/bjs.5762","article-title":"Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases","volume":"94","author":"Bodingbauer","year":"2007","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.suc.2024.04.003_bib34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamasurg.2020.1973","article-title":"Very early recurrence after liver resection for intrahepatic cholangiocarcinoma","volume":"155","author":"Tsilimigras","year":"2020","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.suc.2024.04.003_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.21037\/cco.2018.07.03","article-title":"Intrahepatic cholangiocarcinoma: the AJCC\/UICC 8th edition updates","volume":"7","author":"Lee","year":"2018","journal-title":"Chin Clin Oncol"},{"issue":"5","key":"10.1016\/j.suc.2024.04.003_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000525489","article-title":"Selective internal radiation therapy with yttrium-90 resin microspheres followed by gemcitabine plus cisplatin for unresectable intrahepatic cholangiocarcinoma: a phase 2 single-arm multicenter clinical trial","volume":"11","author":"Chan","year":"2022","journal-title":"Liver Cancer"},{"issue":"7","key":"10.1016\/j.suc.2024.04.003_bib37","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/cncr.25625","article-title":"Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol","volume":"117","author":"Kiefer","year":"2011","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.suc.2024.04.003_bib38","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.23818","article-title":"Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres","volume":"113","author":"Ibrahim","year":"2008","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.suc.2024.04.003_bib39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.suc.2024.04.003_bib40","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1245\/s10434-022-11932-3","article-title":"Drug-eluting bead, irinotecan therapy of unresectable intrahepatic cholangiocarcinoma (DELTIC) with concomitant systemic gemcitabine and cisplatin","volume":"29","author":"Martin","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.suc.2024.04.003_bib41","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.semradonc.2018.06.003","article-title":"Radiotherapy for biliary tract cancers","volume":"28","author":"Keane","year":"2018","journal-title":"Semin Radiat Oncol"},{"issue":"9","key":"10.1016\/j.suc.2024.04.003_bib42","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1245\/s10434-022-11439-x","article-title":"Hepatic arterial infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"29","author":"Holster","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.suc.2024.04.003_bib43","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s11605-023-05606-y","article-title":"Neoadjuvant chemotherapy for intrahepatic, perihilar, and distal cholangiocarcinoma: a national population-based comparative cohort study","volume":"27","author":"Parente","year":"2023","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.suc.2024.04.003_bib44","doi-asserted-by":"crossref","first-page":"100354","DOI":"10.1016\/j.ctarc.2021.100354","article-title":"Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review","volume":"27","author":"Rizzo","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.suc.2024.04.003_bib45","unstructured":"American Cancer Society. Bile duct cancer early detection, Diagnosis, and Staging."},{"issue":"14","key":"10.1016\/j.suc.2024.04.003_bib46","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.suc.2024.04.003_bib47","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","article-title":"Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial","volume":"22","author":"Lamarca","year":"2021","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.suc.2024.04.003_bib48","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ejso.2019.03.023","article-title":"Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis","volume":"45","author":"Yadav","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.suc.2024.04.003_bib49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/bjs.10641","article-title":"Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma","volume":"105","author":"Le Roy","year":"2018","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.suc.2024.04.003_bib50","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.suc.2024.04.003_bib51","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study","volume":"37","author":"Edeline","year":"2019","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610924000586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610924000586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T15:41:15Z","timestamp":1729611675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610924000586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0039610924000586"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2024.04.003","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2024.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}